Luliconazole

卢立康唑

Report date: 2022/04/20 15:23:07
NME

Base Information

Drug NameLuliconazole
Drug Alias NameLuliconazolum氯利康唑luliconazolLuzuLuconac +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsTinea CrurisTinea VersicolorTinea Pedis +[8] 
Global Approved IndicationsTinea VersicolorTinea PedisTinea +[6] 
Approved Indications in ChinaTinea VersicolorTinea PedisTinea +[5] 
Original Approved Country/TerritoryJapan
Original Approved Date2005/04/11
Country/TerritoryBelizeUnited StatesEl Salvador +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNihon Nohyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPola ChemicalMedicis Pharmpharmaceuticals CorpHainan Hailing Chemipharma Corporation Ltd
Inactive CompaniesMedicis Global Service CoSato Pharmaceutical Co LtdTopica Pharmaceuticals Inc +[4] 
Active IndicationsTinea VersicolorTinea PedisTinea +[6] 
Inactive IndicationsTinea CrurisOnychomycosis

Other Information

ATC CodeD01AC18
Related LinksWikipediaDrugBankKEGG